BRANDY MARTINEZ: Open Payments
NPI 1235875527 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,320 in 303 payments from 24 companies in 2025. Trend: 2023 $6,451 · 2024 $7,191 · 2025 $6,320
Food & beverage: $6,312Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $705 |
| Neurocrine BioSciences, Inc. | 27 | $676 |
| Vanda Pharmaceuticals Inc. | 27 | $643 |
| Janssen Pharmaceuticals, Inc | 21 | $591 |
| Otsuka America Pharmaceutical, Inc. | 21 | $491 |
| ABBVIE INC. | 25 | $435 |
| Teva Pharmaceuticals USA, Inc. | 26 | $386 |
| Lundbeck LLC | 20 | $310 |
| Alkermes, Inc. | 12 | $303 |
| Supernus Pharmaceuticals, Inc. | 12 | $258 |
Products named: CAPLYTA, INGREZZA, FANAPT, REXULTI, SPRAVATO, VRAYLAR, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
